Back to mobile site

More on ABUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+50.0% Growth)
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arbutus Biopharma (NQ:ABUS)
Delayed: 4.21 -0.07 (1.64%)
Prev. Close $4.28  
Open$4.28 
52 Wk High$5.88 
52 Wk Low$2.65 
Day High$4.30 
Day Low$4.14 
P/E N/A  
EPS$0.00 
Volume2,526,176 

Friends, Peers and Foes (?): ROIV, MRNA, BGS, BOX, CRWD (more...)

Oct 27, 2026 05:26 PM Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: BlackRock, Inc.
Oct 22, 2026 07:31 AM FDA lifts clinical hold on Arbutus Biopharma's AB-101 drug candidate
Oct 22, 2026 07:31 AM Form 8-K Arbutus Biopharma Corp For: Oct 20
Oct 22, 2026 07:30 AM Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Oct 7, 2026 04:35 PM Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: MORGAN STANLEY
Oct 7, 2026 04:12 PM Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Beardsley Robert A
Oct 7, 2026 04:12 PM Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Nguyen Tuan
Oct 7, 2026 04:10 PM Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Sawhney Roger
Oct 7, 2026 04:09 PM Form 4 Arbutus Biopharma Corp For: Oct 01 Filed by: Androski Lindsay
Oct 7, 2026 06:13 AM Increasing unusual option volume: ABUS PACB DNA GMAB TWST HHH
View All Articles

Entities mentioned with ABUS

View All Entities